Reference is made to the stock exchange announcement by BerGenBio ASA
("BerGenBio") on 16 April 2024 regarding the final results of the last exercise
period for the warrants issued in connection with the rights issue in BerGenBio
in June 2023. 

Investinor Direkte AS ("Investinor") has exercised 107,215,810 warrants and has
therefore today been allocated 107,215,810 new shares in BerGenBio. Following
issuance of the new shares Investinor will hold 217,147,430 shares and votes in
BerGenBio, representing approx. 5.72% of the shares and votes outstanding in

This information is subject to the disclosure requirements pursuant to section
4-2 of the Norwegian Securities Trading Act.

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange